| pubmed-article:12963763 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12963763 | lifeskim:mentions | umls-concept:C0018674 | lld:lifeskim |
| pubmed-article:12963763 | lifeskim:mentions | umls-concept:C1412481 | lld:lifeskim |
| pubmed-article:12963763 | lifeskim:mentions | umls-concept:C0042333 | lld:lifeskim |
| pubmed-article:12963763 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:12963763 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
| pubmed-article:12963763 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12963763 | pubmed:dateCreated | 2003-9-9 | lld:pubmed |
| pubmed-article:12963763 | pubmed:abstractText | The APOE-epsilon4 allele is associated with risk for Alzheimer's disease (AD) and poorer outcome after head injury. Several studies show that polymorphisms in the promoter that influence APOE expression also increase risk for AD. The authors' data from a study of 92 patients are consistent with a possible influence of the G-219T promoter polymorphism on outcome after head injury. The group with unfavorable outcome had a genotype frequency distribution similar to that found in AD. | lld:pubmed |
| pubmed-article:12963763 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12963763 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12963763 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12963763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12963763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12963763 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12963763 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:12963763 | pubmed:issn | 1526-632X | lld:pubmed |
| pubmed-article:12963763 | pubmed:author | pubmed-author:TeasdaleG MGM | lld:pubmed |
| pubmed-article:12963763 | pubmed:author | pubmed-author:MurrayGG | lld:pubmed |
| pubmed-article:12963763 | pubmed:author | pubmed-author:HarrisJ MJM | lld:pubmed |
| pubmed-article:12963763 | pubmed:author | pubmed-author:LendonC LCL | lld:pubmed |
| pubmed-article:12963763 | pubmed:author | pubmed-author:PritchardA... | lld:pubmed |
| pubmed-article:12963763 | pubmed:author | pubmed-author:NicollJ A RJA | lld:pubmed |
| pubmed-article:12963763 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:12963763 | pubmed:day | 9 | lld:pubmed |
| pubmed-article:12963763 | pubmed:volume | 61 | lld:pubmed |
| pubmed-article:12963763 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12963763 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12963763 | pubmed:pagination | 683-5 | lld:pubmed |
| pubmed-article:12963763 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:meshHeading | pubmed-meshheading:12963763... | lld:pubmed |
| pubmed-article:12963763 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12963763 | pubmed:articleTitle | Genetic variation of the APOE promoter and outcome after head injury. | lld:pubmed |
| pubmed-article:12963763 | pubmed:affiliation | Department of Psychiatry, University of Birmingham, UK. c.l.lendon@bham.ac.uk | lld:pubmed |
| pubmed-article:12963763 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12963763 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:348 | entrezgene:pubmed | pubmed-article:12963763 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12963763 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12963763 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12963763 | lld:pubmed |
